# Autism Spectrum Disorder

Type: Technology

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/autism-spectrum-disorder
Canonical HTML page: https://getbiobrief.com/entity/autism-spectrum-disorder

## Recent coverage (1 stories)

### Parental Demand for Off-Label Autism Treatments Outpaces Clinical Evidence
2026-03-16 12:50:54 · Sentiment: Neutral · Impact: 6/10 · Sources: 17

A surge in parental demand for off-label treatments for autism spectrum disorder (ASD) has created a significant rift between families and the medical community. While anecdotal reports drive interest in therapies like GLP-1s and Rett syndrome drugs, physicians cite a lack of robust clinical data and potential safety risks as reasons for their reluctance to prescribe.
Full story: https://getbiobrief.com/story/autism-treatment-demand-vs-clinical-evidence

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.